Journal of Gastrointestinal Surgery

, Volume 17, Issue 1, pp 66–77 | Cite as

Improved Long-Term Survival after Major Resection for Hepatocellular Carcinoma: A Multicenter Analysis Based on a New Definition of Major Hepatectomy

  • Andreas Andreou
  • Jean-Nicolas Vauthey
  • Daniel Cherqui
  • Giuseppe Zimmitti
  • Dario Ribero
  • Mark J. Truty
  • Steven H. Wei
  • Steven A. Curley
  • Alexis Laurent
  • Ronnie T. Poon
  • Jacques Belghiti
  • David M. Nagorney
  • Thomas A. Aloia
  • From the International Cooperative Study Group on Hepatocellular Carcinoma
2012 SSAT Plenary Presentation

Abstract

Background

Advances in the surgical management of hepatocellular carcinoma (HCC) have expanded the indications for curative hepatectomy, including more extensive liver resections. The purpose of this study was to examine long-term survival trends for patients treated with major hepatectomy for HCC.

Patients and Methods

Clinicopathologic data for 1,115 patients with HCC who underwent hepatectomy between 1981 and 2008 at five hepatobiliary centers in France, China, and the USA were assessed. In addition to other performance metrics, outcomes were evaluated using resection of ≥4 liver segments as a novel definition of major hepatectomy.

Results

Major hepatectomy was performed in 539 patients. In the major hepatectomy group, median tumor size was 10 cm (range: 1–27 cm) and 22 % of the patients had bilateral lesions. The TNM Stage distribution included 29 % Stage I, 31 % Stage II, 38 % Stage III, and 2 % Stage IV. The postoperative histologic examination indicated that chronic liver disease was present in 35 % of the patients and tumor microvascular invasion was identified in 60 % of the patients. The 90-day postoperative mortality rate was 4 %. After a median follow-up time of 63 months, the 5-year overall survival rate was 40 %. Patients treated with right hepatectomy (n = 332) and those requiring extended hepatectomy (n = 207) had similar 90-day postoperative mortality rates (4 % and 4 %, respectively, p = 0.976) and 5-year overall survival rates (42 % and 36 %, respectively, p = 0.523). Postoperative mortality and overall survival rates after major hepatectomy were similar among the participating countries (p > 0.1) and improved over time with 5-year survival rates of 30 %, 40 %, and 51 % for the years 1981–1989, 1990–1999, and the most recent era of 2000–2008, respectively (p = 0.004). In multivariate analysis, factors that were significantly associated with worse survivals included AFP level >1,000 ng/mL, tumor size >5 cm, presence of major vascular invasion, presence of extrahepatic metastases, positive surgical margins, and earlier time period in which the major hepatectomy was performed.

Conclusions

This multinational, long-term HCC survival analysis indicates that expansion of surgical indications to include major hepatectomy is justified by the significant improvement in outcomes over the past three decades observed in both the East and the West.

Keywords

Hepatocellular carcinoma Major hepatectomy Multicenter study Long-term survival 

References

  1. 1.
    Ercolani G, Grazi GL, Ravaioli M, et al. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg 2003; 237:536–543.PubMedGoogle Scholar
  2. 2.
    Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001; 234:63–70.PubMedCrossRefGoogle Scholar
  3. 3.
    Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693–699.PubMedCrossRefGoogle Scholar
  4. 4.
    Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2008; 47:82–89.PubMedCrossRefGoogle Scholar
  5. 5.
    Poon RT, Fan ST, Lo CM, et al. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg 2002; 236:602–611.PubMedCrossRefGoogle Scholar
  6. 6.
    Chik BH, Liu CL, Fan ST, et al. Tumor size and operative risks of extended right-sided hepatic resection for hepatocellular carcinoma: implication for preoperative portal vein embolization. Arch Surg 2007; 142:63–69.PubMedCrossRefGoogle Scholar
  7. 7.
    Akai H, Kiryu S, Matsuda I, et al. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: Comparison with triple phase 64 detector row helical CT. Eur J Radiol 2010.Google Scholar
  8. 8.
    Aloia TA, Zorzi D, Abdalla EK, et al. Two-surgeon technique for hepatic parenchymal transection of the noncirrhotic liver using saline-linked cautery and ultrasonic dissection. Ann Surg 2005; 242:172–177.PubMedCrossRefGoogle Scholar
  9. 9.
    Donadon M, Abdalla EK, Vauthey JN. Liver hanging maneuver for large or recurrent right upper quadrant tumors. J Am Coll Surg 2007; 204:329–333.PubMedCrossRefGoogle Scholar
  10. 10.
    Ishizawa T, Mise Y, Aoki T, et al. Surgical technique: new advances for expanding indications and increasing safety in liver resection for HCC: the Eastern perspective. J Hepatobiliary Pancreat Sci 2010; 17:389–393.PubMedCrossRefGoogle Scholar
  11. 11.
    Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 2005; 12:351–355.PubMedCrossRefGoogle Scholar
  12. 12.
    Dahiya D, Wu TJ, Lee CF, et al. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience. Surgery 2010; 147:676–685.PubMedCrossRefGoogle Scholar
  13. 13.
    Capussotti L, Muratore A, Massucco P, et al. Major liver resections for hepatocellular carcinoma on cirrhosis: early and long-term outcomes. Liver Transpl 2004; 10:S64-68.PubMedCrossRefGoogle Scholar
  14. 14.
    Ng KK, Vauthey JN, Pawlik TM, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 2005; 12:364–373.PubMedCrossRefGoogle Scholar
  15. 15.
    Wei AC, Tung-Ping Poon R, Fan ST, et al. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 2003; 90:33–41.PubMedCrossRefGoogle Scholar
  16. 16.
    Melendez J, Ferri E, Zwillman M, et al. Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg 2001; 192:47–53.PubMedCrossRefGoogle Scholar
  17. 17.
    Zhou L, Rui JA, Wang SB, et al. Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy. World J Surg 2007; 31:1782–1787.PubMedCrossRefGoogle Scholar
  18. 18.
    Torzilli G, Makuuchi M, Inoue K, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999; 134:984–992.PubMedCrossRefGoogle Scholar
  19. 19.
    Fan ST, Mau Lo C, Poon RT, et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg 2011; 253:745–758.PubMedCrossRefGoogle Scholar
  20. 20.
    Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003; 138:1198–1206.PubMedCrossRefGoogle Scholar
  21. 21.
    Miyoshi A, Takahashi T, Otsuka T, et al. Efficacy of major hepatectomy for large hepatocellular carcinoma. Hepatogastroenterology 2009; 56:768–772.PubMedGoogle Scholar
  22. 22.
    Bismuth H. Surgical Anatomy and Anatomical Surgery of the Liver. World J Surg 1982; 6:3–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Vauthey JN, Chaoui A, Do KA, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000; 127:512–519.PubMedCrossRefGoogle Scholar
  24. 24.
    Kishi Y, Abdalla EK, Chun YS, et al. Three Hundred and One Consecutive Extended Right Hepatectomies: Evaluation of Outcome Based on Systematic Liver Volumetry. Ann Surg 2009.Google Scholar
  25. 25.
    Abdalla EK, Adam R, Bilchik AJ, et al. Improving resectability of hepatic colorectal metastases: Expert consensus statement. Ann Surg Oncol 2006; 13:1271–1280.PubMedCrossRefGoogle Scholar
  26. 26.
    Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646–649.PubMedCrossRefGoogle Scholar
  27. 27.
    Zorzi D, Laurent A, Pawlik TM, et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007; 94:274–286.PubMedCrossRefGoogle Scholar
  28. 28.
    Leevy CM, Smith F, Longueville J, et al. Indocyanine green clearance as a test for hepatic function. Evaluation by dichromatic ear densitometry. JAMA 1967; 200:236–240.PubMedCrossRefGoogle Scholar
  29. 29.
    Vauthey JN, Lauwers GY, Esnaola NF, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002; 20:1527–1536.PubMedCrossRefGoogle Scholar
  30. 30.
    Couinaud C. Le foie; études anatomiques et chirurgicales. Paris: Masson & Cie 1957.Google Scholar
  31. 31.
    Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7:462–503.PubMedCrossRefGoogle Scholar
  32. 32.
    Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22:696–699.PubMedCrossRefGoogle Scholar
  33. 33.
    Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 2008; 134:1908–1916.PubMedCrossRefGoogle Scholar
  34. 34.
    Halazun KJ, Al-Mukhtar A, Aldouri A, et al. Right hepatic trisectionectomy for hepatobiliary diseases. Ann Surg 2007; 246:1065–1074.PubMedCrossRefGoogle Scholar
  35. 35.
    Abdalla EK, Denys A, Chevalier P, et al. Total and segmental liver volume variations: implications for liver surgery. Surgery 2004; 135:404–410.PubMedCrossRefGoogle Scholar
  36. 36.
    Mullen JT, Ribero D, Reddy SK, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007; 204:854–862.PubMedCrossRefGoogle Scholar
  37. 37.
    Kishi Y, Abdalla EK, Chun YS, et al. Three Hundred and One Consecutive Extended Right Hepatectomies: Evaluation of Outcome Based on Systematic Liver Volumetry. Ann Surg 2009; 250:540–548.PubMedGoogle Scholar
  38. 38.
    Esnaola NF, Mirza N, Lauwers GY, et al. Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France, and Japan. Ann Surg 2003; 238:711–719.PubMedCrossRefGoogle Scholar
  39. 39.
    Kubota K, Makuuchi M, Kusaka K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997; 26:1176–1181.PubMedGoogle Scholar
  40. 40.
    Azoulay D, Castaing D, Krissat J, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 2000; 232:665–672.PubMedCrossRefGoogle Scholar
  41. 41.
    Imamura H, Seyama Y, Makuuchi M, et al. Sequential transcatheter arterial chemoembolization and portal vein embolization for hepatocellular carcinoma: the university of Tokyo experience. Semin Intervent Radiol 2008; 25:146–154.PubMedCrossRefGoogle Scholar
  42. 42.
    Yoo H, Kim JH, Ko GY, et al. Sequential Transcatheter Arterial Chemoembolization and Portal Vein Embolization versus Portal Vein Embolization Only before Major Hepatectomy for Patients with Hepatocellular Carcinoma. Ann Surg Oncol 2011; 18:1251–1257.PubMedCrossRefGoogle Scholar
  43. 43.
    Ogata S, Belghiti J, Farges O, et al. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg 2006; 93:1091–1098.PubMedCrossRefGoogle Scholar
  44. 44.
    Choti MA, Geschwind JF. Preoperative Sequential TACE and PVE to Increase Resectability in the Cirrhotic Patient With HCC. Gastrointest Cancer Res 2008; 2:47–48.PubMedGoogle Scholar
  45. 45.
    Hwang S, Lee SG, Ko GY, et al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg 2009; 249:608–616.PubMedCrossRefGoogle Scholar
  46. 46.
    Farges O, Malassagne B, Flejou JF, et al. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 1999; 229:210–215.PubMedCrossRefGoogle Scholar
  47. 47.
    Sotiropoulos GC, Druhe N, Sgourakis G, et al. Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach? Dig Dis Sci 2009; 54:2264–2273.PubMedCrossRefGoogle Scholar
  48. 48.
    Ruzzenente A, Capra F, Pachera S, et al. Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients. J Gastrointest Surg 2009; 13:1313–1320.PubMedCrossRefGoogle Scholar
  49. 49.
    Ribero D, Abdalla EK, Madoff DC, et al. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 2007; 94:1386–1394.PubMedCrossRefGoogle Scholar
  50. 50.
    Farges O, Belghiti J, Kianmanesh R, et al. Portal vein embolization before right hepatectomy—Prospective clinical trial. Ann Surg 2003; 237:208–217.PubMedGoogle Scholar
  51. 51.
    AJCC Cancer Staging Manual Seventh Edition. New York: Springer, 2010.Google Scholar
  52. 52.
    Varotti G, Ramacciato G, Ercolani G, et al. Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. Eur J Surg Oncol 2005; 31:760–767.PubMedCrossRefGoogle Scholar
  53. 53.
    Lei HJ, Chau GY, Lui WY, et al. Prognostic value and clinical relevance of the 6th edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma. J Am Coll Surg 2006; 203:426–435.PubMedCrossRefGoogle Scholar
  54. 54.
    Vauthey JN, Ribero D, Abdalla EK, et al. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. J Am Coll Surg 2007; 204:1016–1027.PubMedCrossRefGoogle Scholar
  55. 55.
    Pawlik TM, Poon RT, Abdalla EK, et al. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 2005; 140:450–457.PubMedCrossRefGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2012

Authors and Affiliations

  • Andreas Andreou
    • 1
  • Jean-Nicolas Vauthey
    • 1
  • Daniel Cherqui
    • 2
  • Giuseppe Zimmitti
    • 1
  • Dario Ribero
    • 1
  • Mark J. Truty
    • 1
  • Steven H. Wei
    • 1
  • Steven A. Curley
    • 1
  • Alexis Laurent
    • 2
  • Ronnie T. Poon
    • 3
  • Jacques Belghiti
    • 4
  • David M. Nagorney
    • 5
  • Thomas A. Aloia
    • 1
  • From the International Cooperative Study Group on Hepatocellular Carcinoma
  1. 1.Department of Surgical OncologyThe University of Texas MD Anderson Cancer CenterHoustonUSA
  2. 2.Department of Digestive and Hepatobiliary Surgery and Liver TransplantationHôpital Henri MondorCréteilFrance
  3. 3.Department of SurgeryThe University of Hong Kong, Queen Mary HospitalHong KongChina
  4. 4.Department of SurgeryHôpital BeaujonClichyFrance
  5. 5.Department of Gastroenterologic and General Surgery, Mayo ClinicRochesterUSA

Personalised recommendations